Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

986 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect and Safety of Radiation Therapy Boost to Extramesorectal Lymph Nodes in Rectal Cancer.
Chen H, Nguyen KNB, Huang H, Feng C, Zhao X, Daly ME, Rao S, Fragoso R, Valicenti R, Sekhon S, Navarro SM, Kim EJ, Cho M, Tam K, Farkas L, Halabi WJ, Monjazeb AM, Rong Y. Chen H, et al. Among authors: tam k. Pract Radiat Oncol. 2020 Sep-Oct;10(5):e372-e377. doi: 10.1016/j.prro.2019.12.007. Epub 2019 Dec 20. Pract Radiat Oncol. 2020. PMID: 31866577
A phase 1b multicenter study of TAS-102 in combination with irinotecan in patients with advanced recurrent or unresectable gastric and gastroesophageal adenocarcinoma after at least one line of treatment with a fluoropyrimidine and platinum-containing regimen.
Dayyani F, Tam K, Kim EJ, Ejadi S, Valerin J, Taylor TH, Cho MT. Dayyani F, et al. Among authors: tam k. Med Oncol. 2022 May 23;39(5):102. doi: 10.1007/s12032-022-01698-9. Med Oncol. 2022. PMID: 35599264 Free PMC article. Clinical Trial.
A phase I dose escalation, dose expansion and pharmacokinetic trial of gemcitabine and alisertib in advanced solid tumors and pancreatic cancer.
Chen JA, Huynh JC, Wu CY, Yu AM, Matsukuma K, Semrad TJ, Gandara DR, Li T, Riess JW, Tam K, Mack PC, Martinez A, Mahaffey N, Kelly KL, Kim EJ. Chen JA, et al. Among authors: tam k. Cancer Chemother Pharmacol. 2022 Sep;90(3):217-228. doi: 10.1007/s00280-022-04457-9. Epub 2022 Jul 30. Cancer Chemother Pharmacol. 2022. PMID: 35907014 Free PMC article. Clinical Trial.
CDKN2A/p16 inactivation mechanisms and their relationship to smoke exposure and molecular features in non-small-cell lung cancer.
Tam KW, Zhang W, Soh J, Stastny V, Chen M, Sun H, Thu K, Rios JJ, Yang C, Marconett CN, Selamat SA, Laird-Offringa IA, Taguchi A, Hanash S, Shames D, Ma X, Zhang MQ, Lam WL, Gazdar A. Tam KW, et al. J Thorac Oncol. 2013 Nov;8(11):1378-88. doi: 10.1097/JTO.0b013e3182a46c0c. J Thorac Oncol. 2013. PMID: 24077454 Free PMC article.
Survival outcomes and predicting intracranial metastasis in stage III non-small cell lung cancer treated with definitive chemoradiation: Real-world data from a tertiary cancer center.
Thibodeau S, Meem M, Hopman W, Sandhu S, Zalay O, Fung AS, Kartolo A, Digby GC, Al-Ghamdi S, Robinson A, Ashworth A, Owen T, Mahmud A, Tam K, Olding T, de Moraes FY. Thibodeau S, et al. Among authors: tam k. Cancer Treat Res Commun. 2023;36:100747. doi: 10.1016/j.ctarc.2023.100747. Epub 2023 Jul 26. Cancer Treat Res Commun. 2023. PMID: 37531737 Free article.
986 results